Molecules / Tafluprost

Tafluprost API manufacturers

CAS 209860-87-7 ATC S01EE05 Updated 9 July 2026
6
manufacturers with an active filing 5 of them hold a US DMF or a CEP
7
shortage records on file across 3 countries
92
finished-dose makers across 32 regulators
Showing 6 of 6 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

MSN Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tafluprost, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
26 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

AGC

Japan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tafluprost, filing since 2006. Its 2023 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Chirogate International

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tafluprost, filing since 2019. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Cayman Pharma Sro

Czech Republic
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tafluprost, filing since 2021.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Everlight Chemical Industrial

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for tafluprost, filing since 2015.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Asahi Glass

Japan
Makes the API

Registered with SFDA (Saudi Arabia) for tafluprost.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

3 more manufacturers hold filings for tafluprost

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Cayman Pharma SroEverlight Chemical IndustrialAsahi Glass
Open the full list with a free account

Contract manufacturers (1)

Everlight Chemical Ind Taiwan

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (6)

Micro Labs India Sandoz Switzerland Laboratoire Unither France NextPharma SAS France Genetic S. P. A Italy Công ty Cổ phần Dược phẩm CPC1 Hà Nội Vietnam

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map tafluprost for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 7 Recalls 2 Finished dose 6 Contract mfrs 1